Clinical Trial Update: Rates of Gastric Ulcer by Endoscopy in Knee Osteoarthritis Patients Receiving LT-NS001 Versus Naprosyn® [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing LT-NS001 with Naprosyn in knee osteoarthritis; the study reports endoscopic gastric ulcer rates as a safety outcome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• LT-NS001
• Naprosyn (naproxen)

Snippet

Sponsor: Logical Therapeutics | Conditions: Osteoarthritis | Phase 2, Phase 3 | Status: COMPLETED